Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page’s revision tag was updated to v3.5.4, replacing the previous v3.5.3, indicating a new release of the page’s underlying codebase and likely minor fixes or improvements.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision version was updated from v3.5.2 to v3.5.3 without changing the underlying study information presented.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded Hepatocellular carcinoma as a study condition and a Genetic and Rare Diseases Information Center resource link. The page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check73 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check80 days agoChange DetectedMinor UI/layout adjustments and an updated timestamp; no substantive changes to core study content such as eligibility, primary outcomes, or treatment details.SummaryDifference0.1%

Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.